Click here for links to all Expanded Tables of Contents EXPANDED TABLE OF CONTENTS VOLUME 7, NUMBER 11   NOVEMBER 2004 TREATMENT HIGHLIGHTS TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER IN CHILDREN AND ADOLESCENTS Cognitive-behavioral therapy, alone or combined with pharmacotherapy, is found to be more effective than pharmacotherapy alone in the treatment of obsessive-compulsive disorder in children and adolescents. RESIDUAL SYMPTOMS OF DEPRESSION Among patients in remission from a depressive episode, residual symptoms of depression are found to be common and persistent, even with adequate levels of antidepressant medication. DEPRESSION AND ANXIETY AMONG CAREGIVERS OF DEMENTIA PATIENTS Among patients with major depression who are in remission and who are receiving continuation antidepressant treatment, comorbid medical illness is found to be associated with relapse. HALLUCINATIONS, DELUSIONS, AND THE ONSET OF A PSYCHOTIC DISORDER The development of delusional ideation following hallucinatory experiences is found to increase the risk of the development of a psychotic disorder. WEIGHT MAINTENANCE AFTER TREATMENT FOR OBESITY Dichotomous thinking and maximum lifetime weight are found to predict weight regain following weight loss in obese individuals. OF NOTE Interventions to Prevent or Reduce Violent Behavior by Children and Adolescents PSYCHOPHARMACOLOGY NOTE ANTIDEPRESSANT-INDUCED MANIA The likelihood of having a manic conversion while being treated with antidepressants is found to vary with age of patient and type of antidepressant. FDA NEWS AND REVIEW Approval (new indication) of Abilify (aripiprazole). Indication: treatment of acute manic and mixed episodes associated with bipolar disorder Approval (first-time generic). Citalopram hydrobromide -- generic of Celexa ASSESSMENT Vancouver Obsessional Compulsive Inventory (VOCI) RESOURCES Each issue presents descriptions of clinical resources (eg, professional materials, patient handouts) and information on how to receive those materials.